PhenGen Biotech Overview
- Year Founded
-
2012
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
PhenGen Biotech General Information
Description
Developer of biopharmaceutical therapies designed for bacteriophages, or viruses that specifically target bacteria. The company research focuses on engineering these phages to combat multi-drug resistant bacterial infections, aiming to develop new and effective treatments, enabling users to treat bacterial illnesses.
Contact Information
Website
www.phengenbiotech.comCorporate Office
- 1075 Morris Avenue
- Stem Building Room 4-19
- Union New Jersey, NJ 07903
- United States
Corporate Office
- 1075 Morris Avenue
- Stem Building Room 4-19
- Union New Jersey, NJ 07903
- United States
PhenGen Biotech Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | 01-Jan-2016 | Completed | Generating Revenue |
PhenGen Biotech Executive Team (1)
Name | Title | Board Seat |
---|---|---|
Bruno Schremmer MD | Founder & Member |
PhenGen Biotech FAQs
-
When was PhenGen Biotech founded?
PhenGen Biotech was founded in 2012.
-
Who is the founder of PhenGen Biotech?
Bruno Schremmer MD is the founder of PhenGen Biotech.
-
Where is PhenGen Biotech headquartered?
PhenGen Biotech is headquartered in Union New Jersey, NJ.
-
What industry is PhenGen Biotech in?
PhenGen Biotech’s primary industry is Biotechnology.
-
Is PhenGen Biotech a private or public company?
PhenGen Biotech is a Private company.
-
What is PhenGen Biotech’s current revenue?
The current revenue for PhenGen Biotech is
.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »